Intrarenal gene expression of proinflammatory chemokines and cytokines in chronic proteinuric glomerulopathies

Physiological Research

Volumn 56, Issue 2, 2007, Pages 221-226

  Brabcova I ^a   Kotsch, K ^b   Hribova P ^a   Louzecka A ^a   Bartosova K ^a   Hyklova K ^a   Lacha J ^a   Volk, H D ^b   Viklicky O ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemokines; Gene expression; Glomerulonephritis; Proteinuria

Indexed keywords

CHEMOKINE; CYTOKINE; MESSENGER RNA; RANTES;

ADULT; AGED; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; METABOLISM; MIDDLE AGED; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CHEMOKINES; CYTOKINES; FEMALE; GENE EXPRESSION; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROTEINURIA; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34247877707     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. DECKERS JG, VAN DER WOUDE FJ, VAN DER KOOIJ SW, DAHA MR: Synergistic effect of IL-1alpha, IFN-gamma, and TNF-alpha on RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 9: 194-202, 1998.
2. HIRSCHBERG R, WANG S: Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease. Curr Opin Nephrol Hypertens 14: 43-52, 2005.
3. IKEZUMI Y, KANNO K, KARASAWA T, HAN GD, ITO Y, KOIKE H, TOYABE S, UCHIYAMA M, SHIMIZU F, KAWACHI H: The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney Int 66: 1036-1048, 2004.
4. KIM YS, ZHENG S, YANG SH, KIM HL, LIM CS, CHAE DW, CHUN R, LEE JS, KIM S: Differential expression of various cytokine and chemokine genes between proliferative and non-proliferative glomerulonephritides. Clin Nephrol 56: 199-206, 2001.
5. LIM CS, ZHENG S, KIM YS, AHN C, HAN JS, KIM S, LEE JS, CHAE DW, KOO JR, CHUN RW, NOH JW: Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant 16: 269-275, 2001.
6. LIM CS, YOON HJ, KIM YS, AHN C, HAN JS, KIM S, LEE JS, LEE HS, CHAE DW: Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy. Nephrology (Carlton) 8: 21-27, 2003.
7. MEZZANO SA, DROGUETT MA, BURGOS ME, ARDILES LG, AROS CA, CAORSI I, EGIDO J: Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int 57: 147-158, 2000.
8. MEZZANO SA, BARRIA M, DROGUETT MA, BURGOS ME, ARDILES LG, FLORES C, EGIDO J: Tubular NF-κB and AP-1 activation in human proteinuric renal disease. Kidney Int 60: 1366-1377, 2001.
9. MEZZANO S, AROS C, DROGUETT A, BURGOS ME, ARDILES L, FLORES C, SCHNEIDER H, RUIZ-ORTEGA M, EGIDO J: NF-κB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 19: 2505-2512, 2004.
10. OOTAKA T, SAITO T, YUSA A, MUNAKETA T, SOMA J, ABE K: Contribution of cellular infiltration to the progression of IgA nephropathy: a longitudinal immunocytochemical study on repeated biopsy specimens. Nephrology 1: 135-142, 1995.
11. PLATZER C, ODE-HAKIM S, REINKE P, DOCKE WD, EWERT R, VOLK HD: Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 27: 58: 264-268, 1994.
12. RATHANASWAMI P, HACHICHA M, SADICK M, SCHALL TJ, MCCOLL SR: Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 268: 5834-5839, 1993.
13. REMUZZI G, BERTANI T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998.
14. SEGERER S, CUI Y, HUDKINS KL, GOODPASTER T, EITNER F, MACK M, SCHLONDORFF D, ALPERS CE: Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 11: 2231-2242, 2000.
15. SCHLONDORFF D: The role of chemokines in the initiation and progression of renal disease. Kidney Int Suppl 49: S44-S47, 1995.
16. SCHLONDORFF D, NELSON PJ, LUCKOW B, BANAS B: Chemokines and renal disease. Kidney Int 51: 610-621, 1997.
17. WATANABE T, KAWACHI H, IKEZUMI Y, YANAGIHARA T, ODA Y, SHIMIZU F: Glomerular CD8+ cells predict progression of IgA nephropathy. Pediatr Nephrol 16: 561-567, 2001.
18. YANO N, ENDOH M, NOMOTO Y, SAKAI H, FADDEN K, RIFAI A: Phenotypic characterization of cytokine expression in patients with IgA nephropathy. J Clin Immunol 17: 396-403, 1997.
19. ZAENKER M, ARBACH O, HELMCHEN U, GLORIUS P, LUDEWIG S, BRAASCH E: Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil- cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment. Int J Tissue React 26: 85-92, 2004.